Ozempic vs Mounjaro: The Weight Loss Drug Showdown

Hollywood is on them. Your neighbor is on them. But which one actually works better?

Disclaimer: This is not medical advice. Consult your doctor before starting any medication.

What Are These Drugs?

Both are GLP-1 receptor agonists, originally designed for Type 2 diabetes. They slow digestion, reduce appetite, and have become the most talked-about drugs in America.

Clinical Trial Results

Ozempic (Semaglutide): Average weight loss of 15% body weight over 68 weeks.
Mounjaro (Tirzepatide): Average weight loss of 21% body weight over 72 weeks.

On raw numbers, Mounjaro wins. But it's newer, more expensive, and harder to get.

Side Effects

Both cause nausea, especially in the first weeks. Mounjaro tends to have slightly more GI issues initially. Long-term effects are still being studied.

Cost & Availability (US)

Ozempic: ~$900/month without insurance. Widely available.
Mounjaro: ~$1,000/month without insurance. Frequent shortages.

The Verdict

If you can get it and afford it, Mounjaro shows stronger results. If availability is an issue, Ozempic is the proven alternative. Neither is a magic pill—diet and exercise still matter.